Commercial Due Diligence on a Next Generation Medical Training Tool

Commercial Due Diligence on a Next Generation Medical Training Tool

Christine O'Connell • March 18, 2021
Christine O'Connell • March 18, 2021

Share

Client and project overview

  • Conducted commercial due diligence (CDD) for a leading B2B data and information business.
  • Focused on evaluating the commercial attractiveness of the 3DDA solution market. We also validated the investment thesis – that the target would be a strategic extension for our client’s medical book assets because it capitalized on the growing adoption of digital and virtual reality technologies


Key questions

As part of our CDD process, we focused on the following questions:

  • What was the sub-segment size and notional opportunity for 3DDA tools?
  • Who are the addressable users?
  • What is the range of content and related tools used by students and medical /nursing schools for foundational and advanced anatomy courses?
  • To what extent do current solutions address customer needs?
  • What were the relative strengths and weaknesses of the target and competitors’ capabilities and products across the identified use cases/feature set?
  • What were the synergies between our client the target business?


Methodology highlights

  • Conducted targeted interviews with market experts, current and prospective customers of the target company, competitors’ B2B customers, our client’s B2B customers, and competing vendors
  • Sized the relevant sub-segment using both supply and demand-side methodology
  • Re-built the business plan for both B2B and B2C customers within a tight timeframe with limited access to target management/customer data


Results

Based on our insights, our client acquired the company successfully two months after we delivered the project.

Read More

Why Are Private Equity Investors Caring More About DevOps?
By Andrew Keller, Tyler Michaels, & Yiwei Jiang September 11, 2025
DevOps tools enable developers and IT teams to collaborate more effectively, opening up the potential for intriguing ROI. Read why PE investors are becoming more interested in DevOps.
Investing in Healthcare 2025: Stax PE Investor Survey
By Darren Buskirk & Jordan Abrams September 9, 2025
Stax Healthcare vertical has compiled the results of a recent survey, conducted by Stax, highlighting the changing landscape in the Healthcare industry. Read the full report here.
Featured by Reuters: 'It's Europe vs China' as Chinese brands crowd Munich car show
September 8, 2025
Phil Dunne was recently featured amongst several industry experts to weigh in on the growing takeover of Chinese EV manufacturers in Europe. Click here to read the full article.
Featured by Management Consulted: Grant Thornton Acquires Stax
September 5, 2025
Paul Edwards recently sat down with Management Consulted's Jenny Rae to discuss Stax’s growth journey and the positive impact of our partnership with Grant Thornton. Read more.
Stax Advises Bregal Sagemount on its Strategic Growth Investment in Spark Membership
September 5, 2025
Stax congratulates Bregal Sagemount on its recent strategic growth investment in Spark Membership, a category-leading membership management platform. Read more here.
Stax Top 20 Exhibition Organizers Ranked by 2024 Revenue
September 3, 2025
Stax has released its annual Top 20 Ranking of Exhibition Organizers. Stax ranks the exhibitions industry’s leading organizers based on exhibition-organizing revenues in 2024. Read more.
Show More